Skip to main content
Year archive

SYNTARA LIMITED — 2005 filings

All 79 regulatory filings released by SYNTARA LIMITED (SNT) in 2005, sourced directly from the official regulator.

79 Filings
2005 Period
2005 filings (79)
Filing Released Lang
US Filing of Annual Report on Form 20-F 134 pages ?Kb
Regulatory Filings
2005-12-20 English
Bronchitol European Cystic Fibrosis Study Commences 4 pages ?Kb
Regulatory Filings
2005-12-15 English
U.S. Phase III Aridol Trial Enrols First Patent 4 pages ?Kb
Regulatory Filings
2005-12-13 English
Appendix 3B - Exercise of Employee Options 9 pages ?Kb
Regulatory Filings
2005-12-08 English
Quarterly Report to Shareholders 8 pages ?Kb
Regulatory Filings
2005-12-05 English
Exercise of Over-Allotment Option 1 page ?Kb
Regulatory Filings
2005-11-30 English
Change in sub sh'holding & Ceasing to be substantial holder 6 pages ?Kb
Regulatory Filings
2005-11-29 English
Bronchitol Cystic Fibrosis Dose Finding Study Commences 4 pages ?Kb
Regulatory Filings
2005-11-27 English
Change in substantial holding 3 pages ?Kb
Regulatory Filings
2005-11-22 English
Becoming a substantial holder 3 pages ?Kb
Regulatory Filings
2005-11-22 English
Change in substantial holding 2 pages ?Kb
Regulatory Filings
2005-11-20 English
Change of Director's Interest Notice x6 12 pages ?Kb
Regulatory Filings
2005-11-17 English
Becoming a substantial holder 14 pages ?Kb
Major Shareholding Notification
2005-11-16 English
Appendix 3B 9 pages ?Kb
Capital/Financing Update
2005-11-16 English
Appendix 3B 9 pages ?Kb
Regulatory Filings
2005-11-16 English
Becoming a substantial holder 14 pages ?Kb
Regulatory Filings
2005-11-16 English
Change of Director's Interest Notice 2 pages ?Kb
Director's Dealing
2005-11-14 English
AGM Presentations 32 pages ?Kb
AGM Information
2005-11-14 English
Results of Meeting 3 pages ?Kb
Declaration of Voting Results & Voting Rights Announcements
2005-11-14 English
Bronchitol Granted Orphan Drug Status in Europe 3 pages ?Kb
Regulatory Filings
2005-11-13 English
Appendix 3B 9 pages ?Kb
Capital/Financing Update
2005-11-10 English
Pharmaxis completes $87 million Capital Raising 3 pages ?Kb
Capital/Financing Update
2005-11-10 English
Disclosure Notice 1 page ?Kb
Capital/Financing Update
2005-11-10 English
App 3B-Deposit of shrs in connection with US public offering 10 pages ?Kb
Capital/Financing Update
2005-11-09 English
Escrow 9 pages ?Kb
Capital/Financing Update
2005-11-09 English
Global Capital Raising Final US Prospectus 159 pages ?Kb
Regulatory Filings
2005-11-08 English
Pharmaxis announces pricing of Global Capital Raising 3 pages ?Kb
Capital/Financing Update
2005-11-07 English
Trading Halt 2 pages ?Kb
Capital/Financing Update
2005-11-06 English
Ceasing to be a substantial holder 3 pages ?Kb
Major Shareholding Notification
2005-11-02 English
US SEC Form F-1 Amendment No.2 249 pages ?Kb
Regulatory Filings
2005-11-02 English
Appendix 3B 9 pages ?Kb
Capital/Financing Update
2005-10-30 English
Results of General Meeting 1 page ?Kb
Declaration of Voting Results & Voting Rights Announcements
2005-10-27 English
Notification of release of securities from escrow 2 pages ?Kb
Share Issue/Capital Change
2005-10-25 English
Commitments Test Entity - First Quarter Report 5 pages ?Kb
Interim / Quarterly Report
2005-10-24 English
2005 Annual Report 92 pages ?Kb
Regulatory Filings
2005-10-20 English
Amendment No 1 to SEC Form F1 169 pages ?Kb
Regulatory Filings
2005-10-17 English
Investor Presentation 35 pages ?Kb
Investor Presentation
2005-10-17 English
Notice of Annual General Meeting 7 pages ?Kb
Regulatory Filings
2005-10-13 English
Appendix 3B - Exercise of Employee Options 9 pages ?Kb
Regulatory Filings
2005-10-06 English
2005 Financial/ Directors & Auditors Report 45 pages ?Kb
Annual Report
2005-09-28 English
Global Capital Raising 2 pages ?Kb
Regulatory Filings
2005-09-25 English
US SEC Form F-1 Registration Statement 167 pages ?Kb
Regulatory Filings
2005-09-25 English
Updated Investor Presentation 47 pages ?Kb
Investor Presentation
2005-09-25 English
Notice of General Meeting 8 pages ?Kb
Regulatory Filings
2005-09-25 English
Enrolment Commenced in Aridol COPD Study 4 pages ?Kb
Regulatory Filings
2005-09-14 English
Exercise of Employee Options App 3B 9 pages ?Kb
Regulatory Filings
2005-09-08 English
Bronchitol Cystic Fibrosis Trial Results Positive 4 pages ?Kb
Regulatory Filings
2005-08-30 English
Opens on NASDAQ National Market 2 pages ?Kb
Regulatory Filings
2005-08-29 English
Preliminary Final Report 36 pages ?Kb
Annual Report
2005-08-29 English
Lists ADRs on NASDAQ 2 pages ?Kb
Regulatory Filings
2005-08-22 English
Appendix 3B - Issue of Employee Options 9 pages ?Kb
Regulatory Filings
2005-08-21 English
Quarterly Report to Shareholders 7 pages ?Kb
Regulatory Filings
2005-08-16 English
Appendix 3B - Exercise of Options under EOP 9 pages ?Kb
Capital/Financing Update
2005-08-04 English
Proposed Issue of Employee Options 2 pages ?Kb
Capital/Financing Update
2005-08-04 English
Commitments Test Entity - Fourth Quarter Report 5 pages ?Kb
Interim / Quarterly Report
2005-07-28 English
Approval to Begin Canadian Cystic Fibrosis Trial Granted 4 pages ?Kb
Regulatory Filings
2005-07-20 English
FDA grants Bronchitol orphan drug status for Cystic Fibrosis 3 pages ?Kb
Regulatory Filings
2005-07-19 English
Revised Investor Presentation 46 pages ?Kb
Investor Presentation
2005-07-04 English
Investor Presentation 46 pages ?Kb
Investor Presentation
2005-07-03 English
Response to ASX Share Price Query 5 pages ?Kb
Regulatory Filings
2005-06-22 English
Appendix 3B 9 pages ?Kb
Share Issue/Capital Change
2005-06-09 English
Applies to Market Aridol in Europe 3 pages ?Kb
Regulatory Filings
2005-05-18 English
Bronchitol Approved for Patent Use-Special Access Scheme 2 pages ?Kb
Regulatory Filings
2005-05-11 English
Cystic Fibrosis Trial reaches target recruitment 3 pages ?Kb
Regulatory Filings
2005-04-28 English
Commitments Test Entity - Third Quarter Report 5 pages ?Kb
Interim / Quarterly Report
2005-04-21 English
Quarterly Report to Shareholders 7 pages ?Kb
Interim / Quarterly Report
2005-04-14 English
Change in substantial holding 3 pages ?Kb
Major Shareholding Notification
2005-03-14 English
Change of Director's Interest Notice 3 pages ?Kb
Director's Dealing
2005-03-14 English
Updated Investor Presentation 35 pages ?Kb
Investor Presentation
2005-03-07 English
Response to ASX Share Price Query 5 pages ?Kb
Regulatory Filings
2005-03-03 English
Appendix 3B - Employee Option Plan 9 pages ?Kb
Capital/Financing Update
2005-03-03 English
Expands senior management team 2 pages ?Kb
Board/Management Information
2005-03-01 English
US FDA Grants Bronchitol Orhpan Drug Status 3 pages ?Kb
Regulatory Filings
2005-02-22 English
Appendix 3B - Employee Options 9 pages ?Kb
Capital/Financing Update
2005-02-15 English
Half Yearly Report & Half Year Accounts 20 pages ?Kb
Interim / Quarterly Report
2005-02-10 English
Pharmaxis to Commence UK Trial in Cystic Fibrosis 4 pages ?Kb
Capital/Financing Update
2005-02-08 English
Quarterly Report to Shareholders 7 pages ?Kb
Interim / Quarterly Report
2005-02-02 English
Commitments Test Entity - Second Quarter Report 5 pages ?Kb
Interim / Quarterly Report
2005-01-30 English
Applies for Regulatory Approval to market Aridol 3 pages ?Kb
Regulatory Filings
2005-01-17 English